Literature DB >> 4055754

Reaction of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) Cu(II) with Ehrlich cells. Binding of copper to metallothionein and its relationship to zinc metabolism and cell proliferation.

A Kraker, S Krezoski, J Schneider, D Minkel, D H Petering.   

Abstract

The copper complex of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) or CuKTS is reduced and dissociated upon reaction with Ehrlich cells. Titration of the cells with the complex leads to the specific binding of copper to metallothionein with 1 to 1 displacement of its complement of zinc. Under conditions of complete titration of metallothionein, 1.25-2.5 nmol CuKTS/10(7) cells, cellular DNA synthesis is rapidly inhibited but no long term effects on cell proliferation are observed. The kinetics of redistribution of Cu and Zn in Ehrlich cells in culture and in animals were studied after pulse reaction of CuKTS with cells. After exposure of cells to the noncytotoxic concentration of 2.5 nmol of CuKTS/10(7) cells, nonmetallothionein bound copper is lost rapidly from the cells, after which copper in metallothionein decays. New zinc metallothionein is made as soon as exposed cells are placed in culture. New synthesis stops when the level of zinc in metallothionein reaches control levels. A second pulse treatment of cells with CuKTS to displace zinc from metallothionein again stimulates new synthesis of the protein to restore its normal concentration. The kinetics of metal metabolism in Ehrlich cells exposed to 5.5 nmol of CuKTS/10(7) cells, which inhibits cell proliferation, are qualitatively similar except there is a pronounced lag before new zinc metallothionein is synthesized. The Ehrlich ascites tumor in mice responds to CuKTS similarly to cells in culture. It is also shown that cultured Ehrlich cells do not make extra zinc metallothionein in the presence of high levels of ZnCl2, and fail to accumulate copper in the presence of large concentrations of CuCl2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055754

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Kinetic lability of zinc bound to metallothionein in Ehrlich cells.

Authors:  S K Krezoski; J Villalobos; C F Shaw; D H Petering
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

Review 2.  Alzheimer's disease & metals: therapeutic opportunities.

Authors:  Vijaya B Kenche; Kevin J Barnham
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 3.  Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy.

Authors:  Mohammad Namdarghanbari; William Wobig; Susan Krezoski; Niloofar M Tabatabai; David H Petering
Journal:  J Biol Inorg Chem       Date:  2011-08-07       Impact factor: 3.358

4.  Characterization of calf liver Cu,Zn-metallothionein: naturally variable Cu and Zn stoichiometries.

Authors:  P Chen; P Onana; C F Shaw; D H Petering
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

5.  Copper(II) and manganese(III) complexes of N'-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer.

Authors:  Anuraag Shrivastav; Nand K Singh; Pratibha Tripathi; Theresa George; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Biochimie       Date:  2006-03-24       Impact factor: 4.079

6.  A novel zinc bis(thiosemicarbazone) complex for live cell imaging.

Authors:  Disha Dayal; Duraippandi Palanimuthu; Sridevi Vijay Shinde; Kumaravel Somasundaram; Ashoka G Samuelson
Journal:  J Biol Inorg Chem       Date:  2011-03-08       Impact factor: 3.358

Review 7.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

8.  Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation.

Authors:  Catherine Lambert; Heloisa Beraldo; Nicole Lievre; Arlette Garnier-Suillerot; Pierre Dorlet; Milena Salerno
Journal:  J Biol Inorg Chem       Date:  2012-10-27       Impact factor: 3.358

Review 9.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.